Researchers from Kubicek’s and Bock’s groups at CeMM have developed a method to accurately assess the effect of specific drugs in isolated pancreatic tissue by using a refined single-cell RNA sequencing method. Their Genome Biology publication describes their technique to overcome the problem of contaminating RNA molecules in single-cell transcriptomics, allowing for accurate results of dynamic drug responses in pancreatic cells. These findings will support the development of targeted drug therapies for treationg T1 diabetes.
- Injections are two-and-a-half times safer when nurses use revamped guidelines
- Cell ‘membrane on a chip’ could speed up screening of drug candidates for COVID-19
- Asthma does not seem to increase the severity of COVID-19
- Flashes bright when squeezed tight: How single-celled organisms light up the oceans
- Study indicates that Medicaid expansion has led to earlier cancer detection among individuals with low income